1. Home
  2. HWKN vs HAE Comparison

HWKN vs HAE Comparison

Compare HWKN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$141.93

Market Cap

2.8B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$58.85

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWKN
HAE
Founded
1938
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
HWKN
HAE
Price
$141.93
$58.85
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$200.00
$85.38
AVG Volume (30 Days)
117.4K
619.6K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
0.57%
N/A
EPS Growth
12.26
44.54
EPS
3.17
2.46
Revenue
$974,431,000.00
$910,373,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
$6.30
$5.31
P/E Ratio
$41.65
$23.79
Revenue Growth
6.01
N/A
52 Week Low
$102.00
$47.32
52 Week High
$186.15
$87.32

Technical Indicators

Market Signals
Indicator
HWKN
HAE
Relative Strength Index (RSI) 47.78 34.23
Support Level $120.35 $48.47
Resistance Level $155.66 $66.86
Average True Range (ATR) 6.41 1.53
MACD -1.25 -0.14
Stochastic Oscillator 47.66 10.70

Price Performance

Historical Comparison
HWKN
HAE

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: